March 2021 - With the COVID-19 vaccine becoming more readily available, there is the outstanding question of how many people will get vaccinated and will it be enough to help society as a whole achieve herd immunity.
With the COVID-19 vaccine becoming more readily available, there is the outstanding question of how many people will get vaccinated and will it be enough to help society as a whole achieve herd immunity. Although a vaccine may be the path to regain a life of normalcy, a December New York Times survey found that 25% of all Americans “probably or definitely would not take a coronavirus vaccine.1
There are many reasons why people are hesitant to become vaccinated; for some, the thought of getting an injection is reason enough. Tryanphobia, an extreme fear of medical procedures involving injections or hypodermic needles, affects 20% of the population. 2,3 Needle fear (vs phobia) is even greater: In a study evaluating 1,907 children and parents, it was found that 63% of children and 24% of adults were afraid of needles.4 When asked, 7% of adults admitted to vaccine non-adherence due to the fear of needles.
Portal Instruments recognizes this anxiety and is dedicated to helping patients – and society – by developing a needle-free injector. We are not available for vaccine delivery (yet), but we envision a world where our needle-free injector is available and driving an increase in vaccinations and ultimately, helping prevent preventable illnesses.
1 Stolberg, Sheryl Gay. “A New Survey Finds That about a Quarter of Americans Don’t Want to Get Vaccinated.” The New York Times, 15 Dec. 2020. The New York Times, 15 Dec. 2020.
2 “Trypanophobia: Test, Definition, and Causes” Healthline, n.d. Web.
3 Malcolm, Xavia, and Xavia Malcolm. “Trypanophobia- A Fear of Needles.” Health Beat, 29 Jan. 2021, jamaicahospital.org/newsletter/trypanophobia-a-fear-of-needles/
4 Taddio A, Ipp M, Thivakaran S, Jamal A, Parikh C, Smart S, Sovran J, Stephens D, Katz J. Survey of the prevalence of immunization non-compliance due to needle fears in children and adults. Vaccine. 2012 Jul 6;30(32):4807-12. doi: 10.1016/j.vaccine.2012.05.011. Epub 2012 May 19. PMID: 22617633.
November 2024, Cambridge, MA – Seasoned drug delivery executive, Steven Kaufman, to join Portal Instruments as their Chief Commercial Officer. Prior to joining Portal Instruments in November 2024, Steven held executive positions at Stevanato Group, Bespak and SHL Medical.
June 30, 2021 - The National Transgender Discrimination Survey Report on Health and Health Care recorded at least 80% of transgender people have either taken gender-affirming hormone therapy (GAHT) or want to take GAHT at some point.¹
July 2021 - The world we live in and the technology we use are rapidly evolving. But, when it comes to drug delivery methods, the 160-year old technology behind the needle and syringe has yet to catch wind of any radical transformation.
Please fill out the details below and we will get back to you shortly.